The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China: A meta-analysis of randomized controlled trials

BACKGROUND: Apatinib-targeted therapy is considered a promising treatment option for malignancies. This study systematically evaluated the efficacy and safety of the combination of apatinib and S-1 for the treatment of patients with advanced gastric cancer (GC). METHODS: Clinical trials were searche...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Zhou, Changchun, Zhang, Kai, Feng, Yikuan, Zhang, Ruihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392758/
https://www.ncbi.nlm.nih.gov/pubmed/30461630
http://dx.doi.org/10.1097/MD.0000000000013259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392758/
https://www.ncbi.nlm.nih.gov/pubmed/30461630
http://dx.doi.org/10.1097/MD.0000000000013259

Ejemplares similares